Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH/ISH 2016 | Highlights of BSH/ISH 2016

Finbarr Cotter • 18 Apr 2016
BSH/ISH 2016
General

Finbarr Cotter, MD, PhD from British Society of Hematology (BSH) Conferences and Barts Health NHS Trust, UK discusses the highlights from the 2016 Annual Meeting of the BSH and International Society of Hematology (ISH) held in Glasgow, Scotland. Examples include the joint symposia with the American Society of Hematology (ASH) and the area of molecular pathology. Prof Cotter also spoke of how BSH is reorganizing to try to get more involvement at the local level.

More from Finbarr Cotter

Sample of topics under discussion at BSH/ISH 2016
3:15
Sample of topics under discussion at BSH/ISH 2016
Finbarr Cotter • 18 Apr 2016
Issues arising internationally in the field of hematology
1:49
Issues arising internationally in the field of hematology
Finbarr Cotter • 18 Apr 2016
What to expect at upcoming BSH events
1:02
What to expect at upcoming BSH events
Finbarr Cotter • 18 Apr 2016
Introduction to the BSH/ISH conference
1:54
Introduction to the BSH/ISH conference
Finbarr Cotter • 18 Apr 2016

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals